Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Theravance Inc (NASDAQ:THRX)

13.45
BATS BZX Real-Time Price
As of 3:31pm ET
 -0.11 / -0.81%
Today’s Change
10.58
Today|||52-Week Range
23.84
-4.95%
Year-to-Date

Today’s Trading

Previous close13.56
Today’s open13.71
Day’s range13.37 - 13.97
Volume301,389
Average volume (3 months)567,138
Market cap$1.6B
Dividend yield7.41%
Data as of 3:18pm ET, 08/27/2015

Growth & Valuation

Earnings growth (last year)+10.18%
Earnings growth (this year)+87.60%
Earnings growth (next 5 years)+3.00%
Revenue growth (last year)+309.82%
P/E ratioNM
Price/Sales81.32
Price/Book--

Competitors

 Today’s
change
Today’s
% change
IRWDIronwood Pharmaceuti...-0.12-1.09%
MNKDMannkind Corp+0.13+3.56%
ALDRAlder Biopharmaceuti...+0.08+0.19%
INSMInsmed Inc+0.60+2.48%
Data as of 3:33pm ET, 08/27/2015

Financials

Next reporting dateOctober 22, 2015
EPS forecast (this quarter)-$0.03
Annual revenue (last year)$19.5M
Annual profit (last year)-$168.5M
Net profit margin-377.10%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
President, Chief Executive Officer &
Director
Michael W. Aguiar
Chief Financial Officer &
Senior Vice President
Eric d'Esparbes
Corporate headquarters
South San Francisco, California

Forecasts

Partner Offers